191 related articles for article (PubMed ID: 30076264)
21. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
[TBL] [Abstract][Full Text] [Related]
22. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.
Li F; Bai Y; Zhao M; Huang L; Li S; Li X; Chen Y
Ophthalmic Res; 2015; 53(3):109-16. PubMed ID: 25676100
[TBL] [Abstract][Full Text] [Related]
23. PRMT5 is a therapeutic target in choroidal neovascularization.
Muniyandi A; Martin M; Sishtla K; Motolani A; Sun M; Jensen NR; Qi X; Boulton ME; Prabhu L; Lu T; Corson TW
Sci Rep; 2023 Jan; 13(1):1747. PubMed ID: 36720900
[TBL] [Abstract][Full Text] [Related]
24. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.
Kelley MR; Georgiadis MM; Fishel ML
Curr Mol Pharmacol; 2012 Jan; 5(1):36-53. PubMed ID: 22122463
[TBL] [Abstract][Full Text] [Related]
25. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-8 induction by Helicobacter pylori in gastric epithelial cells is dependent on apurinic/apyrimidinic endonuclease-1/redox factor-1.
O'Hara AM; Bhattacharyya A; Mifflin RC; Smith MF; Ryan KA; Scott KG; Naganuma M; Casola A; Izumi T; Mitra S; Ernst PB; Crowe SE
J Immunol; 2006 Dec; 177(11):7990-9. PubMed ID: 17114472
[TBL] [Abstract][Full Text] [Related]
28. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
29. Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis.
Guan Z; Basi D; Li Q; Mariash A; Xia YF; Geng JG; Kao E; Hall JL
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):96-101. PubMed ID: 15539619
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
31. The Inhibitory Effects of Gold Nanoparticles on VEGF-A-Induced Cell Migration in Choroid-Retina Endothelial Cells.
Chan CM; Hsiao CY; Li HJ; Fang JY; Chang DC; Hung CF
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877924
[TBL] [Abstract][Full Text] [Related]
32. Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation.
Song YJ; Lee JY; Joo HK; Kim HS; Lee SK; Lee KH; Cho CH; Park JB; Jeon BH
Biochem Biophys Res Commun; 2008 Mar; 368(1):68-73. PubMed ID: 18206643
[TBL] [Abstract][Full Text] [Related]
33. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
34. Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells.
Kim CS; Son SJ; Kim EK; Kim SN; Yoo DG; Kim HS; Ryoo SW; Lee SD; Irani K; Jeon BH
Cardiovasc Res; 2006 Feb; 69(2):520-6. PubMed ID: 16325162
[TBL] [Abstract][Full Text] [Related]
35. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo.
Lee YR; Park MS; Joo HK; Kim KM; Kim J; Jeon BH; Choi S
Sci Rep; 2018 Jun; 8(1):8701. PubMed ID: 29880821
[TBL] [Abstract][Full Text] [Related]
37. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
Ding J; Fishel ML; Reed AM; McAdams E; Czader MB; Cardoso AA; Kelley MR
Mol Cancer Ther; 2017 Jul; 16(7):1401-1411. PubMed ID: 28446640
[TBL] [Abstract][Full Text] [Related]
38. Novel Small Molecule JP-153 Targets the Src-FAK-Paxillin Signaling Complex to Inhibit VEGF-Induced Retinal Angiogenesis.
Toutounchian JJ; Pagadala J; Miller DD; Baudry J; Park F; Chaum E; Morales-Tirado V; Yates CR
Mol Pharmacol; 2017 Jan; 91(1):1-13. PubMed ID: 27913654
[TBL] [Abstract][Full Text] [Related]
39. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.
Hall JL; Wang X; Van Adamson ; Zhao Y; Gibbons GH
Circ Res; 2001 Jun; 88(12):1247-53. PubMed ID: 11420300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
